FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称LEPZACITINIB
异名/同义词1H-PYRROLO(2,3-B)PYRIDINE-5-CARBOXYLIC ACID, 4-(((3R)-1-(2-CYANOACETYL)-3-PIPERIDINYL)AMINO)-, ETHYL ESTER
ATI1777
ATI-1777
ETHYL (3R)-4-((1-(2-CYANOACETYL)PIPERIDIN-3-YL)AMINO)-1H-PYRROLO(2,3-B)PYRIDINE-5-CARBOXYLATE
ETHYL 4-(((3R)-1-(CYANOACETYL)PIPERIDIN-3-YL)AMINO)-1HPYRROLO( 2,3-B)PYRIDINE-5-CARBOXYLATE
LEPZACITINIB
LEPZACITINIB [INN]
LEPZACITINIB [USAN]
CAS登记号2321488-47-3
物质唯一标识(Unique Ingredient Identifier)DQN3V3R84U
分子式C18H21N5O3
国际化合物标识(International Chemical Identifier,InChI)QQOPOYMFJLUSBI-GFCCVEGCSA-N
SMILESN(c1c2c(ncc1C(OCC)=O)[nH]cc2)[C@H]3CN(C(CC#N)=O)CCC3
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
  • 药品国际非专利名称数据库
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System